Angiocrine Bioscience
Developer of a curative cellular therapies platform designed to treat indications in regenerative medicine and hematopoietic stem cell gene therapy. The company's platform comprises cultured endotheli...
Valuation
$25.1M
Latest known
Share Price
N/A
Total Raised
$88.8M
Last Round
N/A